Visiting Nurse & Hospice Of Fairfield County, Inc in Norwalk, Connecticut

Name	Visiting Nurse & Hospice Of Fairfield County, Inc
Location	761 Main Avenue, Suite 114, Norwalk, Connecticut
Hospice ID	071512
Category	Part of a Home Health Agency
Ownership Type	Voluntary Non-profit - Private
Profit Type	NON-PROFIT
Accreditation Provider	Community Health Accreditation Partner (CHAP)
SSA county code	000

News Archive

High fat, low carb diet improves Alzheimer's disease in mice

A report published today in the BioMed Central, open access journal Nutrition and Metabolism, showed that a brain protein, amyloid-beta, which is an indicator of Alzheimer's disease, is reduced in mice on the so-called ketogenic diet.

DUSA Pharmaceuticals total product revenues for second-quarter 2010 increase 25% to $8.7 million

DUSA Pharmaceuticals, Inc., a dermatology company that is developing and marketing Levulan Photodynamic Therapy and other products focused on patients with common skin conditions, reported today its corporate highlights and financial results for the second quarter ended June 30, 2010.

CSI third quarter revenues increase 5% to $21.2 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.

Elixir Medical announces presentations from EXCELLA II Clinical Trial at 2010 EuroPCR

Elixir Medical Corporation, a developer of innovative drug eluting stent platforms for the treatment of cardiovascular disease, today announced two key presentations scheduled for the 2010 EuroPCR meeting featuring the company's cardiovascular innovations.

Read more Medical News

› Verified 1 days ago

A hospice usually have one NPI number but sometimes it may have multiple NPI numbers. We have found possible NPI number/s associated with Visiting Nurse & Hospice Of Fairfield County, Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1205280799
Organization Name	Visiting Nurse & Hospice Of Fairfield County Inc
Address	761 Main Ave Norwalk, Connecticut, 06851
Phone Number	(203)762-8958

News Archive

High fat, low carb diet improves Alzheimer's disease in mice

A report published today in the BioMed Central, open access journal Nutrition and Metabolism, showed that a brain protein, amyloid-beta, which is an indicator of Alzheimer's disease, is reduced in mice on the so-called ketogenic diet.

DUSA Pharmaceuticals total product revenues for second-quarter 2010 increase 25% to $8.7 million

DUSA Pharmaceuticals, Inc., a dermatology company that is developing and marketing Levulan Photodynamic Therapy and other products focused on patients with common skin conditions, reported today its corporate highlights and financial results for the second quarter ended June 30, 2010.

CSI third quarter revenues increase 5% to $21.2 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.

Elixir Medical announces presentations from EXCELLA II Clinical Trial at 2010 EuroPCR

Elixir Medical Corporation, a developer of innovative drug eluting stent platforms for the treatment of cardiovascular disease, today announced two key presentations scheduled for the 2010 EuroPCR meeting featuring the company's cardiovascular innovations.

Read more Medical News

› Verified 1 days ago

NPI Number	1275043861
Organization Name	Visiting Nurse & Hospice Of Fairfield County, Inc.
Address	761 Main Ave Norwalk, Connecticut, 06851
Phone Number	(203)762-8958

News Archive

High fat, low carb diet improves Alzheimer's disease in mice

A report published today in the BioMed Central, open access journal Nutrition and Metabolism, showed that a brain protein, amyloid-beta, which is an indicator of Alzheimer's disease, is reduced in mice on the so-called ketogenic diet.

DUSA Pharmaceuticals total product revenues for second-quarter 2010 increase 25% to $8.7 million

DUSA Pharmaceuticals, Inc., a dermatology company that is developing and marketing Levulan Photodynamic Therapy and other products focused on patients with common skin conditions, reported today its corporate highlights and financial results for the second quarter ended June 30, 2010.

CSI third quarter revenues increase 5% to $21.2 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.

Elixir Medical announces presentations from EXCELLA II Clinical Trial at 2010 EuroPCR

Elixir Medical Corporation, a developer of innovative drug eluting stent platforms for the treatment of cardiovascular disease, today announced two key presentations scheduled for the 2010 EuroPCR meeting featuring the company's cardiovascular innovations.

Read more Medical News

› Verified 1 days ago

NPI Number	1982606869
Organization Name	Visiting Nurse & Hospice Of Fairfield County, Inc.
Address	761 Main Ave Norwalk, Connecticut, 06851
Phone Number	(203)762-8958

News Archive

High fat, low carb diet improves Alzheimer's disease in mice

A report published today in the BioMed Central, open access journal Nutrition and Metabolism, showed that a brain protein, amyloid-beta, which is an indicator of Alzheimer's disease, is reduced in mice on the so-called ketogenic diet.

DUSA Pharmaceuticals total product revenues for second-quarter 2010 increase 25% to $8.7 million

DUSA Pharmaceuticals, Inc., a dermatology company that is developing and marketing Levulan Photodynamic Therapy and other products focused on patients with common skin conditions, reported today its corporate highlights and financial results for the second quarter ended June 30, 2010.

CSI third quarter revenues increase 5% to $21.2 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.

Elixir Medical announces presentations from EXCELLA II Clinical Trial at 2010 EuroPCR

Elixir Medical Corporation, a developer of innovative drug eluting stent platforms for the treatment of cardiovascular disease, today announced two key presentations scheduled for the 2010 EuroPCR meeting featuring the company's cardiovascular innovations.

Read more Medical News

› Verified 1 days ago

Hospice staff should discuss treatment preferences and patient beliefs and values with patients and/or caregivers. They should also identify and provide interventions to address pain, shortness of breath and constipation (caused by opioids) to improve patient comfort and quality of life. Visiting Nurse & Hospice Of Fairfield County, Inc has the following score in these measures of patient care.
Better than National Average Worse than National Average

Quality Measure	Provider Score	National Score
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care	100.0	98.3
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care	99.3	93.6
Patients who were checked for pain at the beginning of hospice care	97.5	93.9
Patients who got a timely and thorough pain assessment when pain was identified as a problem	95.4	77.7
Patients who were checked for shortness of breath at the beginning of hospice care	99.6	97.3
Patients who got timely treatment for shortness of breath	93.0	94.6
Patients taking opioid pain medication who were offered care for constipation	97.9	93.3

News Archive

High fat, low carb diet improves Alzheimer's disease in mice

A report published today in the BioMed Central, open access journal Nutrition and Metabolism, showed that a brain protein, amyloid-beta, which is an indicator of Alzheimer's disease, is reduced in mice on the so-called ketogenic diet.

DUSA Pharmaceuticals total product revenues for second-quarter 2010 increase 25% to $8.7 million

DUSA Pharmaceuticals, Inc., a dermatology company that is developing and marketing Levulan Photodynamic Therapy and other products focused on patients with common skin conditions, reported today its corporate highlights and financial results for the second quarter ended June 30, 2010.

CSI third quarter revenues increase 5% to $21.2 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.

Elixir Medical announces presentations from EXCELLA II Clinical Trial at 2010 EuroPCR

Elixir Medical Corporation, a developer of innovative drug eluting stent platforms for the treatment of cardiovascular disease, today announced two key presentations scheduled for the 2010 EuroPCR meeting featuring the company's cardiovascular innovations.

Read more Medical News

› Verified 1 days ago

Hospice provide various services either through their own staff or through third-party arrangements. Find the list of services provided by Visiting Nurse & Hospice Of Fairfield County, Inc below:

• By staff
  • Home Health Aide Service
  • Counseling Service
  • Home Maker Service
  • Medical Social Service
  • Nursing Service
  • Physician Service


• Under Arrangement
  • Medical Supply Service
  • Occupational Therapy
  • Physical Therapy
  • Short Term Inpatient care
  • Speech Pathology


• Combination of Staff and Under Arrangement
  • No services


• Type of Short Term Inpatient Care
  • Acute

Number of full time equivalent employees at Visiting Nurse & Hospice Of Fairfield County, Inc

Home Health Aides	4.5
Counselors	1
Homemakers	0.5
Medical Social Workers	0.54
Physicians	0.03
Registered Nurses	2.82
Other Personnel	1.22
Total Employees	10.61

News Archive

High fat, low carb diet improves Alzheimer's disease in mice

A report published today in the BioMed Central, open access journal Nutrition and Metabolism, showed that a brain protein, amyloid-beta, which is an indicator of Alzheimer's disease, is reduced in mice on the so-called ketogenic diet.

DUSA Pharmaceuticals total product revenues for second-quarter 2010 increase 25% to $8.7 million

DUSA Pharmaceuticals, Inc., a dermatology company that is developing and marketing Levulan Photodynamic Therapy and other products focused on patients with common skin conditions, reported today its corporate highlights and financial results for the second quarter ended June 30, 2010.

CSI third quarter revenues increase 5% to $21.2 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.

Elixir Medical announces presentations from EXCELLA II Clinical Trial at 2010 EuroPCR

Elixir Medical Corporation, a developer of innovative drug eluting stent platforms for the treatment of cardiovascular disease, today announced two key presentations scheduled for the 2010 EuroPCR meeting featuring the company's cardiovascular innovations.

Read more Medical News

› Verified 1 days ago

Homemakers	6
Others	0.84
Total Volunteers	6.84

News Archive

High fat, low carb diet improves Alzheimer's disease in mice

A report published today in the BioMed Central, open access journal Nutrition and Metabolism, showed that a brain protein, amyloid-beta, which is an indicator of Alzheimer's disease, is reduced in mice on the so-called ketogenic diet.

DUSA Pharmaceuticals total product revenues for second-quarter 2010 increase 25% to $8.7 million

DUSA Pharmaceuticals, Inc., a dermatology company that is developing and marketing Levulan Photodynamic Therapy and other products focused on patients with common skin conditions, reported today its corporate highlights and financial results for the second quarter ended June 30, 2010.

CSI third quarter revenues increase 5% to $21.2 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.

Elixir Medical announces presentations from EXCELLA II Clinical Trial at 2010 EuroPCR

Elixir Medical Corporation, a developer of innovative drug eluting stent platforms for the treatment of cardiovascular disease, today announced two key presentations scheduled for the 2010 EuroPCR meeting featuring the company's cardiovascular innovations.

Read more Medical News

› Verified 1 days ago

• January, 2009 is the initial visit of the health survey for certifications by CMS.
• It is in compliance at the time of certification survey by CMS.
• It is eligible to participate in the medicare and/or medicaid program.
• Blue Cross (massachusetts) is the Medicare Administrative Contractor (MAC), intermediary or carrier servicing this hospice.
• Current status is Active Provider.
• Reason of certification is Recertification.
• End of fiscal year is on 30, September.
• Related Provider Number is 077074.

What is Hospice Care?
Hospice care is a type of care and philosophy of care that focuses on the palliation of a chronically ill, terminally ill or seriously ill patient's pain and symptoms, and attending to their emotional and spiritual needs. Care may be provided in a patient's home or in a designated facility such as nursing home, hospital unit or freestanding hospice, with level of care and sometimes location based upon frequent evaluation of the paients needs. The four primary levels of care provided by hospice are routine home care, continuous care, general inpatient and respite care.

How long can one get medicare hospice care?
Hospice care is for people with a life expectancy of 6 months or less (if the disease runs its normal course). If the person receiving hospice care live longer than 6 months, he or she can still get hospice care.

• A person can get hospice care for two 90-day benefit periods, followed by an unlimited number of 60-day benefit periods.
• At the start of each period, the hospice medical director or other hospice doctor must recertify that the person is terminally ill (with a life expectancy of 6 months or less). This step is must for continued hospice care.